CS logo
small CS logo
Chaim Sheba Medical Center; Hematology BMT & CBB

Ramat Gan, Israel
Medical center in Ramat Gan
Derech Sheba 2, Ramat Gan
1,580 Beds

About Chaim Sheba Medical Center; Hematology BMT & CBB


Chaim Sheba Medical Center at Tel HaShomer, also Tel HaShomer Hospital, is the largest hospital in Israel, located in the Tel Aviv District city of Ramat Gan at Tel HaShomer neighborhood, Israel. In 2020, Newsweek ranked it as the 9th-best hospital in the world.
There are 1,580 beds in Chaim Sheba Medical Center; Hematology BMT & CBB.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Molecular Templates, Inc.
1
Total Rows: 2

Clinical Trials at Chaim Sheba Medical Center; Hematology BMT & CBB


During the past decade, Chaim Sheba Medical Center; Hematology BMT & CBB conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100001111111111Started TrialsCompleted Trails201520162017201800.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.
2006-09-04
2011-05-26
Completed
545
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
2008-02-04
2017-05-02
Completed
228
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
2011-07-06
2021-07-30
Completed
1,401
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
2012-08-24
2016-09-16
Completed
572
Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL
2015-02-01
2021-03-22
Terminated
38
An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
2018-05-08
2024-11-30
Recruiting
280

Rows per page:

1–6 of 6

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Chaim Sheba Medical Center; Hematology BMT & CBB" #1 collaborator was "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 5Hoffmann-La Roche: 5Molecular Templates, Inc.: 1Molecular Templates, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsGerman Low GradeLymphoma StudyGroup: 1German Low GradeLymphoma StudyGroup: 1Institute of CancerResearch, UnitedKingdom: 1Institute of CancerResearch, UnitedKingdom: 1

Clinical Trials Conditions at Chaim Sheba Medical Center; Hematology BMT & CBB


According to Clinical.Site data, the most researched conditions in "Chaim Sheba Medical Center; Hematology BMT & CBB" are "Non-Hodgkin's Lymphoma" (2 trials), "Blood Cancer" (1 trials), "Diffuse Large B Cell Lymphoma" (1 trials), "Hematological Malignancy" (1 trials) and "Influenza, Human" (1 trials). Many other conditions were trialed in "Chaim Sheba Medical Center; Hematology BMT & CBB" in a lesser frequency.

Clinical Trials Intervention Types at Chaim Sheba Medical Center; Hematology BMT & CBB


Most popular intervention types in "Chaim Sheba Medical Center; Hematology BMT & CBB" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Obinutuzumab" (2 trials), "rituximab [MabThera/Rituxan]" (2 trials), "89Zr-Df-IAB22M2C" (1 trials), "Atezolizumab" (1 trials) and "Bendamustine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Chaim Sheba Medical Center; Hematology BMT & CBB


The vast majority of trials in "Chaim Sheba Medical Center; Hematology BMT & CBB" are 6 trials for "All" genders.

Clinical Trials Status at Chaim Sheba Medical Center; Hematology BMT & CBB


Currently, there are NaN active trials in "Chaim Sheba Medical Center; Hematology BMT & CBB". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Chaim Sheba Medical Center; Hematology BMT & CBB, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Chaim Sheba Medical Center; Hematology BMT & CBB, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 3Phase 3: 3Phase 1: 2Phase 1: 2Phase 2: 2Phase 2: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1